Centre for International Health Protection, Robert Koch Institute, Nordufer 20, Berlin 13353, Germany.
Evidence-Based Public Health, Centre for International Health Protection, Robert Koch Institute, Nordufer 20, Berlin 13353, Germany.
Health Policy Plan. 2022 Apr 13;37(4):505-513. doi: 10.1093/heapol/czab133.
A better understanding of serological data and risk factors for coronavirus disease 2019 (COVID-19) infection in healthcare workers (HCWs) is especially important in African countries where human resources and health services are more constrained. We reviewed and appraised the evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence and its risk factors in HCWs in Africa to inform response and preparedness strategies during the SARS-CoV-2 pandemic. We followed the Preferred Reporting Items for systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines in this scoping review. Databases including PubMed, Embase and preprint servers were searched accordingly from the start of the COVID-19 pandemic to 19 April 2021. Our search yielded 12 peer-reviewed and four pre-print articles comprising data on 9223 HCWs from 11 countries in Africa. Seroprevalence varied widely and ranged from 0% to 45.1%. Seropositivity was associated with older age, lower education, working as a nurse/non-clinical HCW or in gynaecology, emergency, outpatient or surgery departments. Asymptomatic rates were high and half of the studies recommended routine testing of HCWs. This scoping review found a varying but often high SARS-CoV-2 seroprevalence in HCWs in 11 African countries and identified certain risk factors. COVID-19 public health strategies for policy and planning should consider these risk factors and the potential for high seroprevalence among HCWs when prioritizing infection prevention and control measures and vaccine deployment.
更好地了解血清学数据和 2019 年冠状病毒病(COVID-19)在卫生保健工作者(HCWs)中的感染风险因素在人力资源和卫生服务受到更多限制的非洲国家尤为重要。我们审查并评估了 SARS-CoV-2 血清流行率及其在非洲 HCWs 中的风险因素的证据,以为 SARS-CoV-2 大流行期间的应对和准备策略提供信息。我们在这一范围审查中遵循了系统评价和荟萃分析扩展的首选报告项目(PRISMA-ScR)指南。我们相应地从 COVID-19 大流行开始到 2021 年 4 月 19 日在包括 PubMed、Embase 和预印本服务器在内的数据库中进行了搜索。我们的搜索产生了 12 篇同行评审文章和 4 篇预印本文章,其中包含来自非洲 11 个国家的 9223 名 HCWs 的数据。血清流行率差异很大,范围从 0%到 45.1%。血清阳性与年龄较大、受教育程度较低、作为护士/非临床 HCW 或在妇科、急诊、门诊或外科部门工作有关。无症状率很高,一半的研究建议对 HCWs 进行常规检测。这项范围审查发现,11 个非洲国家的 HCWs 中 SARS-CoV-2 血清流行率存在差异,但通常较高,并确定了某些风险因素。COVID-19 公共卫生策略的政策和规划应考虑这些风险因素以及 HCWs 中高血清流行率的可能性,从而优先考虑感染预防和控制措施以及疫苗部署。